One Health applications for prophylactic vaccines and preventive strategies – A joint call by Netherlands Centre for One Health and Top Sector Life Sciences & Health

The Netherlands Centre for One Health (NCOH) was allocated a budget of two million euro Public-Private Partnership (PPP) Allowance to organise and realise their first PPP call. This call involves strategic partnerships under the Knowledge and Innovation Agenda of Top Sector Life Sciences & Health (LSH): One Health call.

The research projects should fit within the NCOH Strategic Research Agenda and one of its Solution Sets ‘Preventive Strategies’ or ‘Prophylactic Vaccines’. All NCOH partners can apply for collaborative innovation projects; though specific NCOH consortium criteria must be met.

Funding conditions

Depending on the type of research (fundamental, industrial or experimental) and the contributions by private and public partners within the project, between €250,000 and €750,000 PPP Allowance can be applied for. Submitted projects should have a total size of max. €1 million, including co-financing. An important condition is that an application must consist of a collaboration with at least one private party and an NCOH consortium of at least two contributing NCOH partners with multiple PhD students, befitting the NCOH research programme.

More information

Please download the “One Health call” description here and read more about the call and the requirements for applications. The call application form and annexes are the same as for the PPP Allowance Match Call. The NCOH advises applicants to use the services of their own Partner Organisations (e.g. experts from research support office, technology transfer office (TTO) or a lawyer) for details on the call and writing of the proposal. Additional NCOH information can be requested through Vincent Rijsman, of the Veterinary Faculty Utrecht University, who functioned as the liason between NCOH and Top Sector LSH.

Submission

Applications can be submitted until 9 October 2019 (12.00 CE(S)T) to Jovanka Bestebroer by the main applicant.

More News

Antibiotic resistance in the Netherlands under control

Contamination with resistant bacteria in patients admitted to Dutch hospitals does not result in higher mortality than contamination by non-resistant bacteria. Although the problem of antibiotic resistance in the Netherlands currently seems manageable, it is important to remain vigilant in view of the ever-changing epidemiology of resistant bacteria, according to Wouter Rottier, who was awarded... More

Volunteering to become ill to help researchers

Radboudumc has combined its research into controlled human infection models to create a new program: the Radboudumc Controlled Human Infection Models (RCHIM). By studying the interaction between pathogens and humans under controlled conditions, researchers can improve their understanding of the underlying disease mechanisms. This understanding contributes to a more targeted development of medicines and vaccines... More

Twitter account NCOH: @ncohnl

In January 2016, NCOH’s own bilingual Twitter account, @ncohnl, was registered. With investigators in the field of one health as a primary target group, via this Twitter account relevant developments in the context of one health are highlighted.

More

Mortality from Q fever adjusted upwards: 95 people died

During the Q fever outbreak from 2007-2010, an unprecedented number of people became infected with the Q fever bacterium Coxiella burnetii. Of all patients who die of chronic Q fever, 55 percent died within one year of diagnosis.

More